Abstract
Sentinel lymph node (SLN) biopsy for the treatment of ductal carcinoma in situ (DCIS) is not necessary and generally should be limited to those patients with a core needle biopsy diagnosis of DCIS who are undergoing mastectomy. Used in this way, SLN biopsy will spare the majority of patients with occult invasive tumor the need for axillary lymph node dissection.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 15-20 |
| Number of pages | 6 |
| Journal | Cancer |
| Volume | 95 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jul 1 2002 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Cancer Research
- Oncology
Cite this
Sentinel lymph node biopsy in patients with ductal carcinoma in situ : A proposal. / McMasters, Kelly M.; Chao, Celia; Wong, Sandra L.; Martin, Robert C G; Edwards, Michael J.
In: Cancer, Vol. 95, No. 1, 01.07.2002, p. 15-20.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Sentinel lymph node biopsy in patients with ductal carcinoma in situ
T2 - A proposal
AU - McMasters, Kelly M.
AU - Chao, Celia
AU - Wong, Sandra L.
AU - Martin, Robert C G
AU - Edwards, Michael J.
PY - 2002/7/1
Y1 - 2002/7/1
N2 - Sentinel lymph node (SLN) biopsy for the treatment of ductal carcinoma in situ (DCIS) is not necessary and generally should be limited to those patients with a core needle biopsy diagnosis of DCIS who are undergoing mastectomy. Used in this way, SLN biopsy will spare the majority of patients with occult invasive tumor the need for axillary lymph node dissection.
AB - Sentinel lymph node (SLN) biopsy for the treatment of ductal carcinoma in situ (DCIS) is not necessary and generally should be limited to those patients with a core needle biopsy diagnosis of DCIS who are undergoing mastectomy. Used in this way, SLN biopsy will spare the majority of patients with occult invasive tumor the need for axillary lymph node dissection.
UR - http://www.scopus.com/inward/record.url?scp=0036644987&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036644987&partnerID=8YFLogxK
U2 - 10.1002/cncr.10641
DO - 10.1002/cncr.10641
M3 - Article
VL - 95
SP - 15
EP - 20
JO - Cancer
JF - Cancer
SN - 0008-543X
IS - 1
ER -